SURGICAL PROPHYLAXIS OUTCOMES IN PATIENTS WITH INHERITED VON WILLEBRAND'S DISEASE IN A SINGLE CENTER

被引：0
|
作者：
Velarde Lopezdeayala, P. [1 ]
Dominguez Rodriguez, J. [1 ]
Diaz Roldan, B. [1 ]
Carranco Falcon, A. [1 ]
机构：
[1] Juan Ramon Jimenez Hosp, Hematol, Huelva, Spain
来源：
HAEMOPHILIA | 2021年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
ABS230
引用
收藏
页码：147 / 148
页数：2
相关论文
共 50 条
  • [31] Outcomes of long-term von Willebrand factor prophylaxis use in von Willebrand disease: A systematic literature review
    El Alayli, Abdallah
    Petersen, Romina Brignardello
    Husainat, Nedaa M.
    Kalot, Mohamad A.
    Aljabiri, Yazan
    Turkmani, Hani
    Britt, Alec
    El-Khechen, Hussein
    Shahid, Shaneela
    Roller, John
    Motaghi, Shahrzad
    Mansour, Razan
    Tosetto, Alberto
    Abdul-Kadir, Rezan
    Laffan, Michael
    Weyand, Angela
    Leebeek, Frank W. G.
    Arapshian, Alice
    Kouides, Peter
    James, Paula
    Connell, Nathan T.
    Flood, Veronica H.
    Mustafa, Reem A.
    HAEMOPHILIA, 2022, 28 (03) : 373 - 387
  • [32] Prophylaxis in von Willebrand disease with von Willebrand factor concentrate and nonfactor therapies
    Kwawegen, Calvin B. van
    Leebeek, Frank W. G.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2024, 8 (08)
  • [33] Operative management and outcomes in patients with von willebrand disease
    Zulfikar, B.
    Koc, B.
    Ak, G.
    Dikici, F.
    Karaman, I
    Atalar, A.
    Bezgal, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1184 - 1184
  • [34] Efficacy and safety of a VWF/FVIII concentrate (wilate®) in inherited von Willebrand disease patients undergoing surgical procedures
    Srivastava, A.
    Serban, M.
    Werner, S.
    Schwartz, B. A.
    Kessler, C. M.
    HAEMOPHILIA, 2017, 23 (02) : 264 - 272
  • [35] Effectiveness of individualized management using WILFACTIN® in patients with von Willebrand disease during surgical procedures: A single-center study
    Rugeri, Lucia
    Benoit, Remi
    Desage, Stephanie
    Dargaud, Yesim
    THROMBOSIS RESEARCH, 2022, 220 : 88 - 90
  • [36] PROPHYLAXIS WITH RECOMBINANT VON WILLEBRAND FACTOR IN PATIENTS WITH SEVERE VON WILLEBRAND DISEASE: PHASE 3 TRIAL RESULTS
    Leebeek, Frank W. G.
    Peyvandi, Flora
    Escobar, Miguel
    Tiede, Andreas
    Castaman, Giancarlo
    Gu, Joan
    Mellgard, Bjorn
    Ewenstein, Bruce
    Ozen, Gulden
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : E62 - E63
  • [37] Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study results
    Leebeek, Frank W. G.
    Peyvandi, Flora
    Escobar, Miguel
    Tiede, Andreas
    Castaman, Giancarlo
    Wang, Michael
    Wynn, Tung
    Baptista, Jovanna
    Wang, Yi
    Zhang, Jingmei
    Mellgard, Bjorn
    Ozen, Gulden
    BLOOD, 2022, 140 (02) : 89 - 98
  • [38] Prophylaxis in von Willebrand Disease: Coming of Age?
    Saccullo, Giorgia
    Makris, Mike
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2016, 42 (05): : 498 - 506
  • [39] PROPHYLAXIS IN VON WILLEBRAND DISEASE HOW AND WHO?
    Biguzzi, E.
    HAEMOPHILIA, 2022, 28 : 10 - 10
  • [40] The need for prophylaxis in von Willebrand's disease and other coagulation disorders
    Street, A
    Berntorp, E
    THROMBOSIS RESEARCH, 2006, 118 : S1 - S2
12345